Racecadotril
Hidrasec 30 mg is a medicine used to treat diarrhea.
Hidrasec 30 mg is a medicine used to treat symptoms of acute diarrhea in children over three months old. The medicine should be taken with a large amount of fluids and a supporting diet when these are not sufficient to control diarrhea and when diarrhea cannot be treated causally.
Racecadotril may be used as a supportive treatment when causal treatment is possible.
Before starting to take Hidrasec 30 mg, consult a doctor or pharmacist if:
Racecadotril, the active substance of Hidrasec, may cause an allergic reaction called angioedema, which can cause swelling of the face, lips, throat, or tongue. If the child experiences such side effects, stop the treatment and contact a doctor immediately. Swelling may occur at any time during treatment with this medicine.
Taking this medicine and some other medicines at the same time may increase the risk of angioedema (see "Hidrasec 30 mg and other medicines").
Skin reactions have been reported in connection with the use of this medicine. In most cases, they are mild and do not require treatment. In some cases, severe skin reactions may occur.
In such cases, stop the treatment immediately and do not give the child racecadotril again.
Severe skin reactions, including drug rash with eosinophilia and systemic symptoms (DRESS), have been reported in connection with racecadotril treatment. If the patient notices any of the symptoms associated with severe skin reactions described in section 4, they should stop taking racecadotril and seek medical attention immediately.
Tell the doctor about all medicines the child is taking or has recently taken, as well as any medicines planned to be given to the child.
Particularly, tell the doctor about medicines the child is taking, as they may increase the risk of certain side effects (see "Warnings and precautions"):
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult a doctor or pharmacist before taking this medicine.
Hidrasec 30 mg is not recommended during pregnancy and breastfeeding.
Hidrasec 30 mg has a minor or no effect on the ability to drive and use machines.
Hidrasec 30 mg contains about 3 g of sucrose in one sachet.
If the doctor has informed about the child's intolerance to some sugars, consult a doctor before giving the child Hidrasec 30 mg.
In children with diabetes, the amount of sucrose taken with Hidrasec 30 mg should be included in the child's daily sugar intake.
Hidrasec 30 mg should always be given to the child according to the doctor's recommendations. In case of doubts, consult a doctor or pharmacist.
Hidrasec 30 mg comes in the form of granules.
The granules should be added to food or mixed with water in a glass or feeding bottle, mixed well, and given to the child immediately.
The recommended dose depends on the child's body weight: 1.5 mg/kg per dose (corresponding to 1-2 sachets), 3 times a day at regular intervals.
For children with a body weight from 13 kg to 27 kg: one sachet per dose.
For children with a body weight of approximately over 27 kg: two sachets per dose.
The doctor will decide on the duration of treatment with Hidrasec 30 mg. Treatment should be continued until two normal stools are passed and should not last longer than 7 days.
To replace lost fluids due to diarrhea, this medicine should be taken with an adequate amount of fluids and salts (electrolytes). The best way to replace fluids and electrolytes is to drink so-called oral rehydration solutions (in case of doubts, consult a doctor or pharmacist).
In case the child takes a higher dose of Hidrasec 30 mg than recommended, consult a doctor or pharmacist immediately.
Do not take a double dose to make up for a missed dose. Take the next dose at the usual time.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Stop giving the child Hidrasec 30 mg and contact a doctor immediately if the following symptoms of angioedema occur:
Stop taking racecadotril and seek medical attention immediately if any of the following symptoms occur:
The following side effects have been reported:
Uncommon (occurring in less than 1 in 100 patients):
tonsillitis, rash, and erythema (redness of the skin).
Frequency not known (cannot be estimated from the available data):
erythema multiforme (pink patches on the skin, inside the mouth, and sometimes on the genitals), tongue, face, mouth, and eyelid swelling, urticaria, erythema nodosum (lumps under the skin), papular rash (small bumps on the skin), pruritus (itching), and generalized pruritus.
If any side effects occur, including any side effects not listed in the leaflet, tell the doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl.
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help gather more information on the safety of the medicine.
Keep the medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the sachet and carton after: Expiry date (EXP). The expiry date refers to the last day of the month stated.
There are no special precautions for storage.
Medicines should not be disposed of via wastewater or household waste. Ask a pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Hidrasec 30 mg is a granule for oral suspension packaged in sachets.
Each pack contains: 10, 16, 20, 30, 50, or 100 sachets.
Not all pack sizes may be marketed.
Bioprojet Europe Ltd.
101 Furry Park road
Killester
Dublin 5
Ireland
Ferrer Internacional, S.A.
Gran Via Carlos III, 94
08028 Barcelona
Spain
Sophartex
21 rue du Pressoir
28500 Vernouillet
France
To obtain more detailed information, contact the local representative of the marketing authorization holder:
Viatris Healthcare Sp. z o.o.
tel. 22 546 64 00
Spain: Tiorfan
Austria: Hidrasec
Belgium: TIORFIX
Czech Republic: Hidrasec
Denmark: Hidrasec
Estonia: Hidrasec
Finland: Hidrasec
Germany: Tiorfan
Greece: Hidrasec
Hungary: Hidrasec
Ireland: Hidrasec
Italy: Tiorfix
Latvia: Hidrasec
Lithuania: Hidrasec
Luxembourg: TIORFIX
Netherlands: HIDRASEC
Norway: Hidrasec
Poland: Hidrasec 30 mg
Portugal: Tiorfan
Slovakia: Hidrasec
Slovenia: Hidrasec
Sweden: Hidrasec
United Kingdom: Hidrasec
Date of last revision of the leaflet:11/2024
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.